Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : Âü¿©¸¶´ç : Q&A : ¿¬±¸°ü·Ã¹®ÀÇ
   
Âü¿©¸¶´ç
QnA
ÆÐ³Î¾à±¹ °Ô½ÃÆÇ
 
 
Á¦   ¸ñ xxxx
ÀÛ¼ºÀÚ ±è¸£¸¦
ÀÛ¼ºÀÏ 2022-05-25
³»   ¿ë Ä«¿À½ºÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ °¡ÆòÃâÀå¾È¸¶ ±èÆ÷ÃâÀå¾È¸¶ ¼ö¿øÃâÀå¾È¸¶ ºÎõÃâÀå¾È¸¶ ÆòÅÃÃâÀå¾È¸¶ ¼º³²ÃâÀå¾È¸¶ ¿ëÀÎÃâÀå¾È¸¶ È­¼ºÃâÀå¾È¸¶ ¾È»êÃâÀå¾È¸¶ ¾È¾çÃâÀå¾È¸¶ ½ÃÈïÃâÀå¾È¸¶ ±¤¸íÃâÀå¾È¸¶ ±ºÆ÷ÃâÀå¾È¸¶ Çϳ²ÃâÀå¾È¸¶ ¿À»êÃâÀå¾È¸¶ ÀÌõÃâÀå¾È¸¶ ¾È¼ºÃâÀå¾È¸¶ ÀÇ¿ÕÃâÀå¾È¸¶ ¾çÆòÃâÀå¾È¸¶ ¿©ÁÖÃâÀå¾È¸¶ °úõÃâÀå¾È¸¶ °í¾çÃâÀå¾È¸¶ ³²¾çÁÖÃâÀå¾È¸¶ ÆÄÁÖÃâÀå¾È¸¶ ÀÇÁ¤ºÎÃâÀå¾È¸¶ ¾çÁÖÃâÀå¾È¸¶ Æ÷õÃâÀå¾È¸¶ µ¿µÎõÃâÀå¾È¸¶ ±¸¸®ÃâÀå¾È¸¶ ¿¬ÃµÃâÀå¾È¸¶ ÃáõÃâÀå¾È¸¶ ¿øÁÖÃâÀå¾È¸¶ °­¸ªÃâÀå¾È¸¶ µ¿ÇØÃâÀå¾È¸¶ ŹéÃâÀå¾È¸¶ ¼ÓÃÊÃâÀå¾È¸¶ »ïôÃâÀå¾È¸¶ ÆòâÃâÀå¾È¸¶ ¸ñÆ÷ÃâÀå¾È¸¶ ¿©¼öÃâÀå¾È¸¶ ¼øÃµÃâÀå¾È¸¶ ³ªÁÖÃâÀå¾È¸¶ ±¤¾çÃâÀå¾È¸¶ ´ã¾çÃâÀå¾È¸¶ °î¼ºÃâÀå¾È¸¶ º¸¼ºÃâÀå¾È¸¶ ÀüÁÖÃâÀå¾È¸¶ ±º»êÃâÀå¾È¸¶ ÀÍ»êÃâÀå¾È¸¶ Á¤À¾ÃâÀå¾È¸¶ ³²¿øÃâÀå¾È¸¶ ±èÁ¦ÃâÀå¾È¸¶ ûÁÖÃâÀå¾È¸¶ ÃæÁÖÃâÀå¾È¸¶ Á¦ÃµÃâÀå¾È¸¶ õ¾ÈÃâÀå¾È¸¶ °øÁÖÃâÀå¾È¸¶ º¸·ÉÃâÀå¾È¸¶ ¾Æ»êÃâÀå¾È¸¶ ¼­»êÃâÀå¾È¸¶ ³í»êÃâÀå¾È¸¶ ´çÁøÃâÀå¾È¸¶ °è·æÃâÀå¾È¸¶ °æÁÖÃâÀå¾È¸¶ Æ÷Ç×ÃâÀå¾È¸¶ ±èõÃâÀå¾È¸¶ ¾Èµ¿ÃâÀå¾È¸¶ ±¸¹ÌÃâÀå¾È¸¶ ¿µÁÖÃâÀå¾È¸¶ ¿µÃµÃâÀå¾È¸¶ »óÁÖÃâÀå¾È¸¶ ¹®°æÃâÀå¾È¸¶ °æ»êÃâÀå¾È¸¶ °í·ÉÃâÀå¾È¸¶ â¿øÃâÀå¾È¸¶ ÁøÁÖÃâÀå¾È¸¶ Å뿵ÃâÀå¾È¸¶ »çõÃâÀå¾È¸¶ ±èÇØÃâÀå¾È¸¶ ¹Ð¾çÃâÀå¾È¸¶ °ÅÁ¦ÃâÀå¾È¸¶ ¾ç»êÃâÀå¾È¸¶ °í¼ºÃâÀå¾È¸¶ °ÅâÃâÀå¾È¸¶ º¥ÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ½É½ÉÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ Á¦ÁÖ½ÃÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ °í°íÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÃÑÆÇÃâÀå¾È¸¶ ÇÖ¹ãÃâÀå¾È¸¶ Á¶Á¶ÃâÀå¾È¸¶ °øÁö»çÇ× ¿¹¾à¾È³» ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ °æ±âµµÃâÀå¾È¸¶ ±èÆ÷ÃâÀå¾È¸¶ ¼ö¿øÃâÀå¾È¸¶ ¼º³²ÃâÀå¾È¸¶ ¾È¾çÃâÀå¾È¸¶ ±¤¸íÃâÀå¾È¸¶ ºÎõÃâÀå¾È¸¶ ÆòÅÃÃâÀå¾È¸¶ ¾È»êÃâÀå¾È¸¶ °í¾çÃâÀå¾È¸¶ °úõÃâÀå¾È¸¶ ±¸¸®ÃâÀå¾È¸¶ ¿À»êÃâÀå¾È¸¶ ½ÃÈïÃâÀå¾È¸¶ ±ºÆ÷ÃâÀå¾È¸¶ Çϳ²ÃâÀå¾È¸¶ ÀÇ¿ÕÃâÀå¾È¸¶ ¿ëÀÎÃâÀå¾È¸¶ ÆÄÁÖÃâÀå¾È¸¶ ÀÌõÃâÀå¾È¸¶ ¾È¼ºÃâÀå¾È¸¶ È­¼ºÃâÀå¾È¸¶ ¾çÁÖÃâÀå¾È¸¶ Æ÷õÃâÀå¾È¸¶ ¿©ÁÖÃâÀå¾È¸¶ ¿¬ÃµÃâÀå¾È¸¶ °¡ÆòÃâÀå¾È¸¶ ¾çÆòÃâÀå¾È¸¶ °­¿øµµÃâÀå¾È¸¶ ÃáõÃâÀå¾È¸¶ °­¸ªÃâÀå¾È¸¶ ¿øÁÖÃâÀå¾È¸¶ ¼ÓÃÊÃâÀå¾È¸¶ »ïôÃâÀå¾È¸¶ ŹéÃâÀå¾È¸¶ µ¿ÇØÃâÀå¾È¸¶ °æ³²ÃâÀå¾È¸¶ â¿øÃâÀå¾È¸¶ ÁøÁÖÃâÀå¾È¸¶ Å뿵ÃâÀå¾È¸¶ »çõÃâÀå¾È¸¶ ±èÇØÃâÀå¾È¸¶ ¹Ð¾çÃâÀå¾È¸¶ °ÅÁ¦ÃâÀå¾È¸¶ ¾ç»êÃâÀå¾È¸¶ °æºÏÃâÀå¾È¸¶ Æ÷Ç×ÃâÀå¾È¸¶ °æÁÖÃâÀå¾È¸¶ ±èõÃâÀå¾È¸¶ ¾Èµ¿ÃâÀå¾È¸¶ ±¸¹ÌÃâÀå¾È¸¶ ¿µÁÖÃâÀå¾È¸¶ ¿µÃµÃâÀå¾È¸¶ »óÁÖÃâÀå¾È¸¶ ¹®°æÃâÀå¾È¸¶ °æ»êÃâÀå¾È¸¶ Àü³²ÃâÀå¾È¸¶ ¸ñÆ÷ÃâÀå¾È¸¶ ¿©¼öÃâÀå¾È¸¶ ¼øÃµÃâÀå¾È¸¶ ³ªÁÖÃâÀå¾È¸¶ ±¤¾çÃâÀå¾È¸¶ ÀüºÏÃâÀå¾È¸¶ ÀüÁÖÃâÀå¾È¸¶ ±º»êÃâÀå¾È¸¶ ÀÍ»êÃâÀå¾È¸¶ Á¤À¾ÃâÀå¾È¸¶ ³²¿øÃâÀå¾È¸¶ ±èÁ¦ÃâÀå¾È¸¶ Ãæ³²ÃâÀå¾È¸¶ õ¾ÈÃâÀå¾È¸¶ °øÁÖÃâÀå¾È¸¶ º¸·ÉÃâÀå¾È¸¶ ¾Æ»êÃâÀå¾È¸¶ ¼­»êÃâÀå¾È¸¶ ³í»êÃâÀå¾È¸¶ °è·æÃâÀå¾È¸¶ ´çÁøÃâÀå¾È¸¶ ÃæºÏÃâÀå¾È¸¶ ûÁÖÃâÀå¾È¸¶ ÃæÁÖÃâÀå¾È¸¶ Á¦ÃµÃâÀå¾È¸¶ ÀÌ¿ëÈıâ Á¶Á¶ÃâÀå¾È¸¶ ¿¹¾à¾È³» °­¿øµµÃâÀå¾È¸¶ ȫõÃâÀå¾È¸¶ Ⱦ¼ºÃâÀå¾È¸¶ ¿µ¿ùÃâÀå¾È¸¶ ÆòâÃâÀå¾È¸¶ Á¤¼±ÃâÀå¾È¸¶ ö¿øÃâÀå¾È¸¶ ȭõÃâÀå¾È¸¶ ¾ç±¸ÃâÀå¾È¸¶ ÀÎÁ¦ÃâÀå¾È¸¶ °í¼ºÃâÀå¾È¸¶ ¾ç¾çÃâÀå¾È¸¶ °æ³²ÃâÀå¾È¸¶ ÀÇ·ÉÃâÀå¾È¸¶ ÇÔ¾ÈÃâÀå¾È¸¶ â³çÃâÀå¾È¸¶ °í¼ºÃâÀå¾È¸¶ ³²ÇØÃâÀå¾È¸¶ Çϵ¿ÃâÀå¾È¸¶ »êûÃâÀå¾È¸¶ ÇÔ¾çÃâÀå¾È¸¶ °ÅâÃâÀå¾È¸¶ ÇÕõÃâÀå¾È¸¶ °æºÏÃâÀå¾È¸¶ ±ºÀ§ÃâÀå¾È¸¶ ÀǼºÃâÀå¾È¸¶ û¼ÛÃâÀå¾È¸¶ ¿µ¾çÃâÀå¾È¸¶ ¿µ´öÃâÀå¾È¸¶ ûµµÃâÀå¾È¸¶ °í·ÉÃâÀå¾È¸¶ ¼ºÁÖÃâÀå¾È¸¶ Ä¥°îÃâÀå¾È¸¶ ¿¹ÃµÃâÀå¾È¸¶ ºÀÈ­ÃâÀå¾È¸¶ ¿ïÁøÃâÀå¾È¸¶ ¿ï¸ªµµÃâÀå¾È¸¶ Ãæ³²ÃâÀå¾È¸¶ ±Ý»êÃâÀå¾È¸¶ ºÎ¿©ÃâÀå¾È¸¶ ¼­ÃµÃâÀå¾È¸¶ û¾çÃâÀå¾È¸¶ È«¼ºÃâÀå¾È¸¶ ¿¹»êÃâÀå¾È¸¶ žÈÃâÀå¾È¸¶ ÃæºÏÃâÀå¾È¸¶ º¸ÀºÃâÀå¾È¸¶ ¿ÁõÃâÀå¾È¸¶ ¿µµ¿ÃâÀå¾È¸¶ ÁõÆòÃâÀå¾È¸¶ ÁøÃµÃâÀå¾È¸¶ ±«»êÃâÀå¾È¸¶ À½¼ºÃâÀå¾È¸¶ ´Ü¾çÃâÀå¾È¸¶ Àü³²ÃâÀå¾È¸¶ ´ã¾çÃâÀå¾È¸¶ °î¼ºÃâÀå¾È¸¶ ±¸·ÊÃâÀå¾È¸¶ °íÈïÃâÀå¾È¸¶ º¸¼ºÃâÀå¾È¸¶ È­¼øÃâÀå¾È¸¶ ÀåÈïÃâÀå¾È¸¶ °­ÁøÃâÀå¾È¸¶ ÇØ³²ÃâÀå¾È¸¶ ¿µ¾ÏÃâÀå¾È¸¶ Á¶Á¶ÃâÀå¾È¸¶ ¹«¾ÈÃâÀå¾È¸¶ ÇÔÆòÃâÀå¾È¸¶ ¿µ±¤ÃâÀå¾È¸¶ À强ÃâÀå¾È¸¶ ¿ÏµµÃâÀå¾È¸¶ ÁøµµÃâÀå¾È¸¶ ½Å¾ÈÃâÀå¾È¸¶ ÀüºÏÃâÀå¾È¸¶ ¿ÏÁÖÃâÀå¾È¸¶ Áø¾ÈÃâÀå¾È¸¶ ¹«ÁÖÃâÀå¾È¸¶ Àå¼öÃâÀå¾È¸¶ ÀÓ½ÇÃâÀå¾È¸¶ ¼øÃ¢ÃâÀå¾È¸¶ °íâÃâÀå¾È¸¶ ºÎ¾ÈÃâÀå¾È¸¶ ±¤¿ª½ÃÃâÀå¾È¸¶ ¼­¿ïÃâÀå¾È¸¶ ÀÎõÃâÀå¾È¸¶ ¼¼Á¾ÃâÀå¾È¸¶ ¿ï»êÃâÀå¾È¸¶ ´ë±¸ÃâÀå¾È¸¶ ºÎ»êÃâÀå¾È¸¶ ´ëÀüÃâÀå¾È¸¶ ±¤ÁÖÃâÀå¾È¸¶ Á¦ÁÖµµÃâÀå¾È¸¶ Á¦ÁÖÃâÀå¾È¸¶ ¼­±ÍÆ÷ÃâÀå¾È¸¶ ÀÌ¿ëÈıâ
       

À̸§
ºñ¹Ð¹øÈ£

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
Á¤±â°£Ç๰ ¾È³» °ü¸®ÀÚ 2012-11-05 2990
¿¬±¸¼Ò Âü¿©°ü·Ã ¾È³» °ü¸®ÀÚ 2011-04-21 3360
55 ssss ±è¸£¸¦ 2022-06-10 14
54 sssss ±è¸£¸¦ 2022-06-08 17
53 ÃâÀå.ÄݰÉ.ÃâÀå¼¥.Äݰɼ¥.¾È¸¶.¸¶»çÁö.ÃâÀ帶»çÁö.ÃâÀå¾È¸¶ Á¶Á¶¼¥ 2022-05-30 28
52 asdfasdfasdf Á¶Á¶¼¥ 2022-05-30 21
51 xxxx ±è¸£¸¦ 2022-05-25 35
50 xxxxx ±è¸£¸¦ 2022-05-23 32
49 xxxxxx ±è¸£¸¦ 2022-05-08 48
48 sssssssssss ±è¸£¸¦ 2022-05-08 49
47 ¤µ¤µ¤µ¤µ¤µ ±è¸£¸¦ 2022-05-07 50
46 ·»Áî°ü·Ã ¹®ÀÇ ±ÇÀ¯ºó 2022-04-22 72
45 ÀÚ·á¿äû¹®ÀÇ ³ëŰï 2022-02-14 157
44 ÀÚ·á¿äû ¹®ÀÇ ÃÖÁö¼ö 2021-08-08 317
43 ÀÚ·á ¿äûµå¸³´Ï´Ù. ÃÖÁö¿ø 2020-03-24 899

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  ´ÙÀ½ 10ÆäÀÌÁö

6
 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»